ReviewBiomolecules & therapeutics2022

Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations.

Krishna Babu Duggirala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.